MENU
+Compare
BFRI
Stock ticker: NASDAQ
AS OF
Jul 25 closing price
Price
$1.06
Change
-$0.05 (-4.50%)
Capitalization
9.77M

BFRI Biofrontera Forecast, Technical & Fundamental Analysis

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy... Show more

BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BFRI with price predictions
Jul 25, 2025

BFRI in upward trend: 10-day moving average crossed above 50-day moving average on July 08, 2025

The 10-day moving average for BFRI crossed bullishly above the 50-day moving average on July 08, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 30, 2025. You may want to consider a long position or call options on BFRI as a result. In of 59 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

BFRI moved above its 50-day moving average on June 30, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where BFRI advanced for three days, in of 161 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 68 cases where BFRI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

BFRI broke above its upper Bollinger Band on July 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BFRI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.039) is normal, around the industry mean (62.701). P/E Ratio (0.000) is within average values for comparable stocks, (88.783). BFRI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.087) is also within normal values, averaging (18.372).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BFRI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BFRI is expected to report earnings to fall 53.19% to -21 cents per share on August 11

Biofrontera BFRI Stock Earnings Reports
Q2'23
Est.
$-0.22
Q1'25
Missed
by $0.28
Q4'24
Beat
by $0.02
Q1'23
Missed
by $0.20
Q4'22
Missed
by $0.04
The last earnings report on May 15 showed earnings per share of -46 cents, missing the estimate of -18 cents. With 55.46K shares outstanding, the current market capitalization sits at 9.77M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
120 Presidential Way
Phone
+1 781 245-1325
Employees
85
Web
https://www.biofrontera-us.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVO4.260.21
+5.19%
Evotec SE
SKYX1.140.03
+2.70%
SKYX Platforms Corp
L91.660.40
+0.44%
Loews Corp
LXU8.520.01
+0.12%
LSB Industries
ZBAI0.42-0.04
-8.20%
ATIF Holdings Limited

BFRI and Stocks

Correlation & Price change

A.I.dvisor tells us that BFRI and CRON have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BFRI and CRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BFRI
1D Price
Change %
BFRI100%
-4.07%
CRON - BFRI
22%
Poorly correlated
-0.97%
COLL - BFRI
21%
Poorly correlated
-1.03%
TLRY - BFRI
21%
Poorly correlated
-2.03%
KMDA - BFRI
20%
Poorly correlated
-0.77%
PLSH - BFRI
17%
Poorly correlated
N/A
More